Aurinia Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA05156V1022
USD
14.81
0.01 (0.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
283.06
235.13
175.51
134.03
45.61
50.12
0.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
283.06
235.13
175.51
134.03
45.61
50.12
0.32
Raw Material Cost
32.67
28.25
14.15
5.66
3.19
1.37
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
67.26
111.29
142.63
128.46
121.24
68.69
13.32
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.33
4.84
2.78
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
101.79
172.03
195.04
196.37
171.44
95.90
22.31
Other Expenses
-3.91
-9.53
-9.58
-8.35
-7.01
-1.84
3.95
Total Expenditure (Excl Depreciation)
166.96
221.06
258.83
247.02
225.77
147.60
75.17
Operating Profit (PBDIT) excl Other Income
116.1
14.1
-83.3
-113
-180.2
-97.5
-74.9
Other Income
4.04
21.32
8.62
6.64
-0.04
-5.29
-12.22
Operating Profit (PBDIT)
139.58
54.83
-63.05
-103.65
-177.44
-101.40
-87.07
Interest
4.33
4.84
2.78
0.00
0.00
0.00
0.00
Exceptional Items
-1.65
-23.11
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
250.39
206.89
161.37
128.37
42.42
48.75
0.00
Depreciation
19.45
19.45
11.65
2.71
2.76
1.37
1.17
Profit Before Tax
114.16
7.45
-77.47
-106.35
-180.21
-102.77
-88.24
Tax
-173.05
1.70
0.55
1.83
0.76
-0.09
0.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
287.20
5.75
-78.02
-108.18
-180.97
-102.68
-88.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
287.20
5.75
-78.02
-108.18
-180.97
-102.68
-88.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
287.20
5.75
-78.02
-108.18
-180.97
-102.68
-88.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
581.33
377.48
377.95
405.44
479.09
407.75
298.60
Earnings per share (EPS)
2.07
0.04
-0.54
-0.76
-1.4
-0.87
-0.95
Diluted Earnings per share
2.07
0.04
-0.54
-0.76
-1.4
-0.87
-0.95
Operating Profit Margin (Excl OI)
41.01%
5.98%
-47.47%
-84.3%
-395.05%
-194.5%
-23906.92%
Gross Profit Margin
47.2%
11.44%
-37.5%
-77.33%
-389.09%
-202.33%
-27380.5%
PAT Margin
101.47%
2.45%
-44.45%
-80.71%
-396.81%
-204.88%
-27794.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 20.42% vs 33.96% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 4,851.72% vs 107.44% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 304.48% vs 146.72% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -10.42% vs 71.43% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Aurinia Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
283.06
263.50
19.56
7.42%
Other Operating Income
0.00
0.00
0.00
Total Operating income
283.06
263.50
19.56
7.42%
Raw Material Cost
32.67
209.12
-176.45
-84.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
67.26
0.00
67.26
Power Cost
0
0
0.00
Manufacturing Expenses
4.33
0.00
4.33
Selling and Distribution Expenses
101.79
152.32
-50.53
-33.17%
Other Expenses
-3.91
30.03
-33.94
-113.02%
Total Expenditure (Excl Depreciation)
166.96
661.71
-494.75
-74.77%
Operating Profit (PBDIT) excl Other Income
116.09
-398.21
514.30
129.15%
Other Income
4.04
10.31
-6.27
-60.81%
Operating Profit (PBDIT)
139.58
-340.58
480.16
140.98%
Interest
4.33
0.00
4.33
Exceptional Items
-1.65
-5.14
3.49
67.90%
Gross Profit (PBDT)
250.39
54.38
196.01
360.45%
Depreciation
19.45
47.32
-27.87
-58.90%
Profit Before Tax
114.16
-393.05
507.21
129.04%
Tax
-173.05
-2.07
-170.98
-8,259.90%
Provisions and contingencies
0
0
0.00
Profit After Tax
287.20
-390.98
678.18
173.46%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
287.20
-390.98
678.18
173.46%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
287.20
-390.98
678.18
173.46%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
581.33
698.58
-117.25
-16.78%
Earnings per share (EPS)
2.07
-1.09
3.16
289.91%
Diluted Earnings per share
2.07
-1.09
3.16
289.91%
Operating Profit Margin (Excl OI)
41.01%
-151.12%
0.00
192.13%
Gross Profit Margin
47.20%
-131.20%
0.00
178.40%
PAT Margin
101.47%
-148.38%
0.00
249.85%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 28.31 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.42% vs 33.96% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 28.72 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 4,851.72% vs 107.44% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.55 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 304.48% vs 146.72% in Dec 2024

Annual - Interest
Interest 0.43 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -10.42% vs 71.43% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.01%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024